• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 424B3 filed by MSP Recovery Inc.

    5/5/25 5:28:20 PM ET
    $MSPR
    EDP Services
    Technology
    Get the next $MSPR alert in real time by email
    424B3 1 333-265953_424b3_no.31.htm 424B3 424B3

    Filed Pursuant to Rule 424(b)(3)

    Registration No. 333-265953

    PROSPECTUS SUPPLEMENT NO. 31

    (to Prospectus dated August 5, 2022)

    img63015796_0.jpg

    MSP RECOVERY, INC.

    Up to 6,369,856 Shares of Class A Common Stock

    Up to 755,200,000 Warrants to Purchase Shares of Class A Common Stock

    Up to 1,652,127 Shares of Class A Common Stock Underlying Warrants

    This prospectus supplement no. 31 amends and supplements the prospectus dated August 5, 2022 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (No. 333-265953). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on May 1, 2025 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement.

    This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prospectus (the “Selling Securityholders”), or their permitted transferees, of up to 6,369,856 shares of our Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”) issued or issuable to certain Selling Securityholders (the “Total Resale Shares”), as follows:

    •
    up to 1,208,840 shares of Class A Common Stock issued or issuable to the Selling Securityholders, including the Sponsor (as defined below), upon the exercise of up to 325,000 Private Warrants (as defined below) and up to 755,200,000 New Warrants (as defined below), and the resale from time to time of such New Warrants. The Private Warrants were originally included in the Private Units (as defined below) issued in a private placement simultaneously with the Company.
    •
    up to 9,200 shares of Common Stock issued to certain Selling Securityholders, including the Sponsor, in connection with the Business Combination (as defined below) upon conversion of the Founder Shares (as defined below). The Founder Shares were originally issued at a price of $3.125 per share.
    •
    up to 1,040 shares of Class A Common Stock included in the Private Units, which were originally issued to certain Selling Securityholders, including the Sponsor, together with the Private Warrants at a price of $250.00 per unit.
    •
    up to 5,068,749 shares of Class A Common Stock exchangeable for Up-C Units originally issued to certain Selling Securityholders, including the Members (as defined below), as consideration in the Business Combination for their membership interests in the MSP Purchased Companies (as defined below) or issuable pursuant to the terms of existing contracts.
    •
    up to 80,036 shares of Class A Common Stock issued to certain Selling Securityholders upon exchange of Up-C Units designated by the Members and issued in a private placement by the Company in lieu of a corresponding number of Up-C Units to which such Members were otherwise entitled but designated back to the Company and

    Opco pursuant to the terms of the Business Combination. Such Selling Securityholders paid no cash consideration for such Up-C Units or the underlying shares of Common Stock.
    •
    up to 1,991 shares of Class A Common Stock issued to certain Selling Securityholders in a private placement by the Company pursuant to the terms of existing contracts. Such Selling Securityholders paid no cash consideration for such shares of Common Stock.

    In addition, this prospectus relates to the issuance by us of up to 1,652,127 shares of our Class A Common Stock issuable upon exercise of warrants as follows:

    •
    7,252 shares of Class A Common Stock issuable upon the exercise of up to 4,532,405 Public Warrants (as defined below), which were originally issued in the initial public offering of units of the Company at a price of $250.00 per unit, with each unit consisting of one share of Class A Common Stock and one-half of one Public Warrant. Following anti-dilution adjustments made in connection with the Business Combination, the Public Warrants have an exercise price of $0.0625 per share. Because the exercise price of the Public Warrants is only $0.0625 per share, we believe holders of the Public Warrants will likely exercise their Public Warrants. However, given the low exercise price, we would only receive nominal proceeds (less than $500) therefrom.
    •
    1,644,875 shares of Class A Common Stock issuable upon the exercise of up to 1,028,046,326 New Warrants (as defined below), which were originally distributed to stockholders of the Company without charge as a dividend pursuant to the terms of the Business Combination. The New Warrants have an exercise price of $7,187.50 per share. The exercise price of the New Warrants are highly dependent on the price of our Class A Common Stock and the spread between the exercise price of the New Warrants and the price of our Common Stock at the time of exercise. If the market price for our Class A Common Stock is less than $7,187.50 per share, we believe warrant holders will be unlikely to exercise their New Warrants. The last reported sale price of the Class A Common Stock, as indicated below, is currently significantly below the $7,187.50 per share exercise price. There is no guarantee therefore that holders will exercise the New Warrants, and in any event, even if holders exercise New Warrants, we will not retain any proceeds from the exercise of the New Warrants, as described below. We do not expect to rely on the cash exercise of the New Warrants to fund our operations. Instead, we intend to rely on our primary sources of cash discussed elsewhere in this prospectus to continue to support our operations. See “The Company and Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources” for additional information.

    Our Common Stock, Public Warrants and New Warrants are listed on Nasdaq under the symbols “MSPR,” “MSPRZ,” and “MSPRW.” On May 2, 2025, the closing price of Common Stock was $1.92 per share, the closing price of our Public Warrants was $0.0164 per warrant and the closing price of our New Warrants was $0.0024 per warrant.

    Effective at 11:59 PM EDT on November 15, 2024, the Company amended its Second Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware to effect a 1-for-25 reverse stock split of the Company’s common stock (the “Reverse Split”). Unless otherwise noted, the share and per share information in this Prospectus Supplement No. 31 have been adjusted to give effect to the Reverse Split.

    Investing in our securities involves risks. Before you invest in our securities, please carefully read the information provided in the “Risk Factors” section beginning on page 9 of the Prospectus and any in any applicable prospectus supplement, and Item IA of our Annual Report on Form 10-K for the fiscal year ending December 31, 2024, filed with the SEC on April 16, 2025.

    Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

     

     

    The date of this prospectus supplement is May 5, 2025.


     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(D)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): April 24, 2025

     

    MSP Recovery, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

     

     

     

     

    Delaware

    (State or other jurisdiction
    of incorporation)

    001-39445

    (Commission
    File Number)

    84-4117825

    (I.R.S. Employer
    Identification No.)

     

     

    3150 SW 38th Avenue

    Suite 1100

    Miami, Florida

    33146

    (Address of principal executive offices)

    (Zip Code)

    (305) 614-2222

    (Registrant’s telephone number, including area code)

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐

    Written communications pursuant to Rule 425 under the Securities Act

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class

    Trading

    Symbol(s)

    Name of each exchange

    on which registered

    Class A Common stock, $0.0001 par value per share

    MSPR

    Nasdaq Capital Market

     

     

     

     

     

    Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $7,187.50 per share

    MSPRW

    Nasdaq Capital Market

     

     

     

     

     

    Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $0.0625 per share

     

    MSPRZ

     

    Nasdaq Capital Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


     

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    On April 24, 2025, MSP Recovery, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of ($128,409,000), as reported in the Company’s Form 10-K for the year ended December 31, 2024, was below the required minimum of $2.5 million, and because, as of April 24, 2025, the Company did not meet the alternative compliance standards, relating to the market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.

    The Company has 45 calendar days from April 24, 2025, or through Monday, June 9, 2025, to submit a plan to regain compliance with Listing Rule 5550(b)(1). If Nasdaq accepts the Company’s plan, Nasdaq may grant an extension of up to 180 calendar days from April 24, 2025, or through Tuesday, October 21, 2025, to regain compliance. If Nasdaq does not accept the Company’s plan, the Company will have the right to appeal such decision to a Nasdaq hearings panel.

    The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market, subject to the Company’s compliance with the other continued listing requirements.

    Item 9.01. Financial Statements and Exhibits.

    (d)
    Exhibits

    Exhibit

    Number

    Description

    104

    Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

     

     


     

     

     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

     

    MSP RECOVERY, INC.

    Dated: May 1, 2025

     

     

     

     

     

     

     

    By:

    /s/ Alexandra Plasencia

     

     

    Name:

    Alexandra Plasencia

     

     

    Title:

    General Counsel

     

     


    Get the next $MSPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MSPR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MSPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results

      MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ:MSPR) ("MSP," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announced financial results for the fiscal year and fourth quarter ended December 31, 2024. "MSP Recovery has overcome significant industry challenges to become the leader in enforcing Medicare Secondary Payer laws, protecting the Medicare Trust Fund, and paving the road for healthcare reimbursement recoveries," said MSP Recovery Founder and CEO John H. Ruiz. "We've made legal and technological progress, holding primary payers accountable. Through pioneering legal strategy and healthcare in

      4/16/25 6:06:05 AM ET
      $MSPR
      EDP Services
      Technology
    • MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Restructuring of Existing Agreements to Remove Corporate Guaranteed Debt by over $1.2 Billion as Well as New Agreements Aimed at Driving Future Growth

      MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ:MSPR) ("MSP Recovery" or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, is pleased to announce that it entered into a strategic term sheet ("Term Sheet") agreeing to several restructuring transactions with Hazel Partners Holdings, LLC ("Hazel"), Virage Capital Management ("Virage"), and their respective affiliates. These initiatives are designed to reduce costs of the Company through a New Servicer entity (as defined below), deleverage the Company by converting certain debt of significant creditors into equity and release $1.2 billion of debt guaranteed

      4/10/25 7:26:38 PM ET
      $MSPR
      EDP Services
      Technology
    • MSP Recovery, Inc. D/B/A LifeWallet, Begins Trading Today Under New NASDAQ Ticker Symbol LIFW

      CORAL GABLES, Fla., Jan. 03, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. D/B/A LifeWallet ("LifeWallet", or "the Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced the Company will commence trading of its common stock today, January 3, 2023 at 9:30 AM ET, under the new ticker symbol "LIFW". MSP Recovery, Inc. previously announced on Dec 22, 2022 that it will begin doing business as "LifeWallet" in 2023. The "LIFW" ticker symbol will replace the Company's current ticker symbol for its common stock, "MSPR". Additionally, the Company's publicly traded warrants to purchase common stock will begin trading under the ti

      1/3/23 1:03:47 AM ET
      $MSPR
      EDP Services
      Technology

    $MSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by MSP Recovery Inc. (Amendment)

      SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

      2/16/24 6:56:25 PM ET
      $MSPR
      EDP Services
      Technology
    • SEC Form SC 13G/A filed by MSP Recovery Inc. (Amendment)

      SC 13G/A - MSP Recovery, Inc. (0001802450) (Subject)

      2/14/24 11:01:29 AM ET
      $MSPR
      EDP Services
      Technology
    • SEC Form SC 13D/A filed by MSP Recovery Inc. (Amendment)

      SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

      2/12/24 6:49:59 PM ET
      $MSPR
      EDP Services
      Technology

    $MSPR
    SEC Filings

    See more
    • SEC Form 424B3 filed by MSP Recovery Inc.

      424B3 - MSP Recovery, Inc. (0001802450) (Filer)

      5/5/25 5:28:23 PM ET
      $MSPR
      EDP Services
      Technology
    • SEC Form 424B3 filed by MSP Recovery Inc.

      424B3 - MSP Recovery, Inc. (0001802450) (Filer)

      5/5/25 5:28:23 PM ET
      $MSPR
      EDP Services
      Technology
    • SEC Form 424B3 filed by MSP Recovery Inc.

      424B3 - MSP Recovery, Inc. (0001802450) (Filer)

      5/5/25 5:28:26 PM ET
      $MSPR
      EDP Services
      Technology

    $MSPR
    Financials

    Live finance-specific insights

    See more
    • MSP Recovery, Now Doing Business as LifeWallet, Entered into a Term Sheet for the Monetization of a Portion of Its Company-owned Assignor Interests as a New Source of Monetization for $275 Million, and Payment of $48 Million in Servicing Fees for 2023

      CORAL GABLES, Fla., Jan. 02, 2023 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ:MSPR) ("MSPR", "MSP Recovery", the "Company," or "LIFW"), which recently announced that it will begin doing business as LifeWallet in 2023 and that its ticker symbol will change to "LIFW" at the beginning of 2023, today announced that the Company entered into a term sheet relating to the sale of a portion of its Company owned Assignor Interests, as defined and as further described below, and certain other transactions (the "Term Sheet"). In the ordinary course of its business, LIFW acquires assignments of recoveries from health insurance payors, healthcare providers and others, and uses its proprietary multi-

      1/2/23 11:56:54 PM ET
      $CANO
      $MSPR
      $PLTR
      Medical/Nursing Services
      Health Care
      EDP Services
      Technology
    • MSP Recovery Announces Fiscal Third Quarter 2022 Financial Results

      Recognized Gain on Debt Extinguishment of $63 Million During the Quarter Paid Value of Potentially Recoverable Claims Grew to $89.2 Billion During the Quarter Increase in Total Claims Recovery Income and Service Income of $3.0 Million over the Second Quarter Purchased Additional $48.2 Million in Future Recoveries and Signed a $7.5 Million Licensing Deal for LifeWallet CORAL GABLES, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ:MSPR) ("MSPR," "MSP Recovery," or the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced financial results for the third quarter ended September 30, 2022. MSPR continu

      11/8/22 5:42:00 PM ET
      $MSPR
      EDP Services
      Technology
    • MSP Recovery to Report Third Quarter 2022 Results on Wednesday, November 9, 2022

      CORAL GABLES, Fla., Oct. 23, 2022 (GLOBE NEWSWIRE) -- MSP Recovery, LLC, a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, today announced that the Company will release its third quarter 2022 financial results after the market closes on Tuesday, November 8, 2022. MSP Recovery will host a conference call and live webcast to review the Company's third quarter results for investors and analysts at 8:00 a.m. Eastern Time on Wednesday, November 9, 2022. To access this call, we encourage you to pre-register using this link: MSP Recovery Q3 2022 Earnings Pre Registration. A live webcast of the conference call will be accessible from the Investor

      10/23/22 6:49:03 PM ET
      $MSPR
      EDP Services
      Technology

    $MSPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Ruiz John Hasan bought $500,000 worth of MSP Recovery (467,290 units at $1.07), increasing direct ownership by 6,772% to 474,190 units (SEC Form 4)

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      10/26/23 10:07:52 AM ET
      $MSPR
      EDP Services
      Technology
    • Quesada Frank Carlos bought $1,500,000 worth of MSP Recovery (6,868,132 units at $0.22), increasing direct ownership by 4,944% to 7,007,041 units (SEC Form 4)

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      10/2/23 5:04:11 PM ET
      $MSPR
      EDP Services
      Technology

    $MSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Palantir Technologies Inc. claimed ownership of 593,438 shares (SEC Form 3)

      3 - MSP Recovery, Inc. (0001802450) (Issuer)

      4/8/25 8:19:25 PM ET
      $MSPR
      EDP Services
      Technology
    • Cano Health, Inc. sold $174,275 worth of shares (221,246 units at $0.79) (SEC Form 4)

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      2/15/24 7:52:58 PM ET
      $MSPR
      EDP Services
      Technology
    • Cano Health, Inc. sold $97,810 worth of shares (124,923 units at $0.78) (SEC Form 4)

      4 - MSP Recovery, Inc. (0001802450) (Issuer)

      2/12/24 6:44:11 PM ET
      $MSPR
      EDP Services
      Technology